PERTINAX PHARMA LIMITED
BRISTOL

Hellopages » Gloucestershire » South Gloucestershire » BS34 8RB

Company number 09557364
Status Active
Incorporation Date 23 April 2015
Company Type Private Limited Company
Address FUTURE SPACE UWE NORTH GATE FILTON ROAD, STOKE GIFFORD, BRISTOL, ENGLAND, BS34 8RB
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration twenty-three events have happened. The last three records are Statement of capital following an allotment of shares on 15 March 2017 GBP 17.5958 ; Resolutions RES11 ‐ Resolution of removal of pre-emption rights ; Registered office address changed from Future Space Uwe North Gate, Filton Road Stoke Gifford Bristol BS34 8QZ England to Future Space Uwe North Gate, Filton Road Stoke Gifford Bristol BS34 8QZ on 16 November 2016. The most likely internet sites of PERTINAX PHARMA LIMITED are www.pertinaxpharma.co.uk, and www.pertinax-pharma.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and ten months. The distance to to Bristol Parkway Rail Station is 1.1 miles; to Bristol Temple Meads Rail Station is 3.7 miles; to Avonmouth Rail Station is 6.4 miles; to Chepstow Rail Station is 11 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Pertinax Pharma Limited is a Private Limited Company. The company registration number is 09557364. Pertinax Pharma Limited has been working since 23 April 2015. The present status of the company is Active. The registered address of Pertinax Pharma Limited is Future Space Uwe North Gate Filton Road Stoke Gifford Bristol England Bs34 8rb. . COOPER, Ashley Stephen Charles is a Director of the company. DARBY, Rosalind May is a Director of the company. GIBSON, Stuart James is a Director of the company. REDMOND, Michele Emily, Dr is a Director of the company. MERCIA FUND MANAGEMENT (NOMINEES) LIMITED is a Director of the company. Director ALEXANDROFF, James Michael has been resigned. Director SUNDSTROM, Susan Margaret has been resigned. The company operates in "Research and experimental development on biotechnology".


Current Directors

Director
COOPER, Ashley Stephen Charles
Appointed Date: 18 September 2015
65 years old

Director
DARBY, Rosalind May
Appointed Date: 01 June 2016
58 years old

Director
GIBSON, Stuart James
Appointed Date: 08 December 2015
58 years old

Director
REDMOND, Michele Emily, Dr
Appointed Date: 18 September 2015
49 years old

Director
MERCIA FUND MANAGEMENT (NOMINEES) LIMITED
Appointed Date: 04 April 2016

Resigned Directors

Director
ALEXANDROFF, James Michael
Resigned: 07 August 2016
Appointed Date: 04 April 2016
67 years old

Director
SUNDSTROM, Susan Margaret
Resigned: 01 June 2016
Appointed Date: 23 April 2015
68 years old

PERTINAX PHARMA LIMITED Events

29 Mar 2017
Statement of capital following an allotment of shares on 15 March 2017
  • GBP 17.5958

20 Mar 2017
Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights

16 Nov 2016
Registered office address changed from Future Space Uwe North Gate, Filton Road Stoke Gifford Bristol BS34 8QZ England to Future Space Uwe North Gate, Filton Road Stoke Gifford Bristol BS34 8QZ on 16 November 2016
11 Oct 2016
Statement of capital following an allotment of shares on 29 July 2016
  • GBP 13.6958

11 Oct 2016
Registered office address changed from Red, Senate House Tyndall Avenue Bristol BS8 1th England to Future Space Uwe North Gate, Filton Road Stoke Gifford Bristol BS34 8QZ on 11 October 2016
...
... and 13 more events
15 Dec 2015
Appointment of Mr Stuart James Gibson as a director on 8 December 2015
24 Sep 2015
Registered office address changed from Red Senate House, Tyndal Ave, Bristol Al BS8 1th United Kingdom to Red, Senate House Tyndall Avenue Bristol BS8 1th on 24 September 2015
24 Sep 2015
Appointment of Mr Ashley Stephen Charles Cooper as a director on 18 September 2015
24 Sep 2015
Appointment of Dr Michele Emily Redmond as a director on 18 September 2015
23 Apr 2015
Incorporation
Statement of capital on 2015-04-23
  • GBP .01
  • MODEL ARTICLES ‐ Model articles adopted